With the pandemic outbreak, the need for home security has become even more pressing. It has also increased the need for security among businesses and individuals.

Its Hirsch Velocity Software now includes contact tracing for reopened office buildings. The company has created a wearable Body Temperature Measurement Patch to monitor people's body temperatures as stadiums and theme parks reopen.

As a result, Identiv's recurring revenue increased 13 percent in the second quarter, and its backlog of orders increased 100 percent compared to the same quarter last year, indicating that the company's future appears bright.

This is an organic food company, and its market value has risen in tandem with the brisk growth of the organic foods market. SunOpta is one of the companies with inexpensive stocks to purchase right now. Since the restructure, the company has operated in three distinct business segments.

Plant-based foods and beverages, fruit-based foods and beverages, and global ingredients are the segments.

SunOpta recorded a 13 percent adjusted revenue growth with impressive revenue growth from all three business segments.

Furthermore, they received the company's second-highest adjusted (earnings before interest, taxes, depreciation, and amortization) in history.

Founded: 1973

Market Cap: 540.452M

Website: www.sunopta.com

AMC is the largest movie theater operator in the United States and one of the companies with cheap stocks to buy right now. Due to the pandemic, it has been forced to close its doors for months. Customers are still afraid to be in confined spaces with other people, even as theaters reopen.

AMC is a risky investment whose future is largely dependent on one thing: a vaccine. Shareholders will be rewarded if a cure for the virus is developed within the next few months. However, unless AMC can find a way to make customers feel safe in theaters, it will succumb to its mounting debt. The bull case makes AMC's low price point appear obvious, but the bears are currently winning.

Stock Price is US$4.32

Founded: 1920
Market Cap: 10.12B
Website: www.amctheatres.com

There are some industries that will suffer as long as there is no vaccine. Live concerts and events will be canceled until the public feels safe enough to return. This is where LiveXLive Media enters the picture. A company that used to simply digitize concerts for your screen, but has since shifted its focus to live streaming and pay-per-view quarantine concerts. So far, their results have been impressive. The company had a record fiscal year in 2021, with revenue increasing by 15% and subscribers increasing by 25%.

LiveXLive is fully in growth mode and shows no signs of slowing down, with a 336 percent year-over-year increase in the number of events streamed this year and a 179 percent increase in hours streamed. However, when concert venues begin to fill up again, the company will most likely have to rethink its business model. Until then, LiveXLive is one of the few companies taking advantage of a global pandemic.

Stock Price is US$4.25

Founded: 2004
Market Cap: $0.24 B
Website: livexlive.com

For most cannabis businesses, 2019 was a nightmare. They were getting ready to put a difficult year behind them and look forward to a better year. They had no idea what this year would bring, and companies like OrganiGram have had to adjust to the new reality.

To cut costs, OrganiGram had to cut 25% of its workforce and reduce cannabis production at its Canadian facility in New Brunswick.

A necessary sacrifice for a company whose Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) turned negative last quarter due to higher sales costs.

OrganiGram has struggled in recent months, but the company may emerge from the under-five-dollar stock market after the pandemic. They can streamline and become more cost-effective than ever before – and at an attractive price for investors.

Stock price is US $1.80

Founded: 2010
Market Cap: 529.379M
Website: www.organigram.ca

The investment thesis for cheap stocks in the biopharmaceutical industry is usually predicated on the success of a new drug in clinical trials.

Catalyst is one of the few companies with a successful drug already on the market: Firdapse. Firdapse is used to treat Lambert-Eaton myasthenic syndrome, also known as LEMS.

The treatment has been a success, with Catalyst experiencing a 134 percent quarter-to-quarter increase in revenue during the first quarter of 2021 as a result of Firdapse.

Despite the fact that the market for LEMS treatments is small (about one in every million people has LEMS), Firdapse is currently being tested as a treatment for muscle-specific kinase myasthenia gravis and Spinal Muscular Atrophy Type 3.

If either of these trials is successful by the end of the trials, Catalyst will have newer, larger markets into which to expand, and shareholders will continue to profit.

Stock price is US $3.54, making it one of the cheapest stocks to buy right now.

Founded: 2002
Market Cap: 798.649M
Website: catalystpharma.com

The pandemic did not appear to be limited to Aphria. This could explain why they currently have one of the cheapest stocks to buy.

While cannabis stocks have struggled to achieve profitability, Aphria has distinguished itself by reporting positive adjusted EBITDA for the last four quarters in a row.

The cannabis industry's largest cash balance is approximately 515 million Canadian dollars ($379.4 million) in cash and cash equivalents. That's especially encouraging in the midst of the pandemic.

While others struggle, Aphria reported a 65 percent increase in net revenue and sold 14,014 kilograms of cannabis in the third quarter, a 98 percent increase from 7,062 kilograms sold in the second quarter.

The price of cannabis has also dropped, from CA$1.11 in the previous quarter to CA$0.93 in the most recent period. In other words, Aphria produced more marijuana at a lower price while also selling more marijuana last quarter – a winning combination for shareholders.

The stock price has been updated to US $8.30, which is higher than the under-five-dollar stocks but still a good buy right now.

Founded: 2014
Market Cap: $4.87 B
Website: https://aphria.ca/

With the 5G network gaining traction around the world, Nokia has an opportunity to reclaim its former dominance.

Furthermore, the recent shift in many governments' attitudes toward using Huawei equipment to build those 5G networks gives the company an advantage.

However, because this rollout will take time, investors should keep an eye on how Nokia strengthens its balance sheet in the meantime. Late last year, the company discontinued its dividend in order to focus funding on the development of 5G infrastructure, and it has slowly but steadily clawed its way to positive free cash flow.

If Nokia can demonstrate that it has its house in order and is well positioned to capitalize on the opportunities that have been presented to it, its low price point today may look like a steal in a few months.

Stock Price is US $ 3.28.

Founded: 1865
Market Cap: 33.158B
Website: www.nokia.com